Showing 41 - 60 results of 128,074 for search '(( i e decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.87s Refine Results
  1. 41

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
  2. 42

    Growth, ammonium metabolism, and photosynthetic properties of <i>Ulva australis</i> (Chlorophyta) under decreasing pH and ammonium enrichment - Fig 5 by Leah B. Reidenbach (4620856)

    Published 2017
    “…<p><b>(A) Light saturation point (E</b><sub><b>k</b></sub><b>), (B) initial slope of the curve (</b>α<b>), and (C) slope of photoinhibition at high photon flux densities (</b>β<b>) from rapid light curves for <i>Ulva australis</i> grown under ambient and enriched NH</b><sub><b>4</b></sub><sup><b>+</b></sup> <b>treatments across a range of pH</b><sub><b>T</b></sub>. …”
  3. 43
  4. 44

    Aquaporin 2 Mutations in <i>Trypanosoma brucei gambiense</i> Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol by Fabrice E. Graf (469055)

    Published 2013
    “…Here we describe two different kinds of <i>TbAQP2</i> mutations found in <i>T. b. gambiense</i> field isolates: simple loss of <i>TbAQP2</i>, or loss of wild-type <i>TbAQP2</i> allele combined with the formation of a novel type of <i>TbAQP2/3</i> chimera. The identified mutant <i>T. b. gambiense</i> are 40- to 50-fold less sensitive to pentamidine and 3- to 5-times less sensitive to melarsoprol than the reference isolates. …”
  5. 45
  6. 46
  7. 47
  8. 48

    S5 Fig - by Meihui Chen (1670020)

    Published 2022
    Subjects:
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
  18. 58
  19. 59

    IFN-β mRNA induction but IFN protein decrease in all mammalian cells upon ONNV infection. by Susanne E. Biesold (194461)

    Published 2011
    “…(E) Comparison of mRNA fold-induction of IFN stimulated genes (<i>MxA</i> and <i>ISG56</i>) to secreted IFN protein at time points 0 hpi and 24 hpi. …”
  20. 60